Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · AggiornatoIl CDC emette un avviso di livello 4 entro il 31 dicembre?
Il CDC emette un avviso di livello 4 entro il 31 dicembre?
Sì
$71,475 Vol.
$71,475 Vol.
31 dic 2026
Sì
$71,475 Vol.
$71,475 Vol.
31 dic 2026
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Mercato aperto: Jan 19, 2026, 3:15 PM ET
Volume
$71,475Data di fine
31 dic 2026Mercato aperto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
This market will resolve to "Yes" if the CDC issues a Level 4 (“Avoid All Travel”) Travel Health Notice for any disease by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
A Level 4 notice listed for any amount of time during this market’s timeframe will suffice for a "Yes" resolution.
The primary resolution source for this market will be the CDC’s official Travel Health Notices page (https://wwwnc.cdc.gov/travel/notices); however, a consensus of credible reporting will also be used.
Volume
$71,475Data di fine
31 dic 2026Mercato aperto
Jan 19, 2026, 3:15 PM ETResolver
0x65070BE91...Current CDC Travel Health Notices remain at Level 2 for polio circulation across 32 countries and Level 1 for dengue in 16 others, with no Level 4 advisories active as of mid-May 2026. The recent hantavirus outbreak linked to a cruise ship prompted only a low-level CDC emergency activation and targeted clinician alerts, without evidence of sustained U.S. transmission or extreme risk thresholds. Historical patterns show Level 4 notices require novel pathogens or uncontrolled epidemics exceeding current surveillance data, and no such escalation appears imminent before year-end. Traders assign roughly 77.5 percent probability to no issuance, reflecting stable epidemiological indicators and the absence of model forecasts projecting rapid deterioration.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato
Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti